Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Income from Non-Controlling Interests (2020 - 2023)

Historic Income from Non-Controlling Interests for Immucell (ICCC) over the last 4 years, with Q2 2023 value amounting to -$1.4 million.

  • Immucell's Income from Non-Controlling Interests fell 10166.89% to -$1.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$6.0 million, marking a year-over-year decrease of 1189087.92%. This contributed to the annual value of -$2.5 million for FY2022, which is 308526.16% down from last year.
  • As of Q2 2023, Immucell's Income from Non-Controlling Interests stood at -$1.4 million, which was down 10166.89% from -$2.3 million recorded in Q1 2023.
  • In the past 5 years, Immucell's Income from Non-Controlling Interests ranged from a high of $513287.0 in Q1 2022 and a low of -$2.3 million during Q1 2023
  • For the 4-year period, Immucell's Income from Non-Controlling Interests averaged around -$551285.8, with its median value being -$441303.0 (2021).
  • The largest annual percentage gain for Immucell's Income from Non-Controlling Interests in the last 5 years was 21631.17% (2022), contrasted with its biggest fall of 234979.9% (2022).
  • Immucell's Income from Non-Controlling Interests (Quarter) stood at $188830.0 in 2020, then plummeted by 60.74% to $74134.0 in 2021, then tumbled by 2349.8% to -$1.7 million in 2022, then grew by 17.28% to -$1.4 million in 2023.
  • Its Income from Non-Controlling Interests stands at -$1.4 million for Q2 2023, versus -$2.3 million for Q1 2023 and -$1.7 million for Q4 2022.